NexImmune

Kristi Jones, Pharm.D., CEO

Oct. 11 | 5:00pm | Oxford Biomedica Ballroom  

Gaithersburg, MD 

(NASDAQ: NEXI) 

In-person Presentation 

NexImmune is a rapidly growing leader in the emerging field of antigen-directed immunotherapies. We are developing a novel technology that uses natural biology to orchestrate a targeted cell-mediated immune response across a broad range of diseases. We can customize our technology to intensify a targeted immune response to treat cancer or infectious disease. Conversely, we can also customize it to dampen an overactive immune response to treat autoimmune disorders. 

www.neximmune.com 



By using this website you agree to accept our Privacy Policy and Terms & Conditions